Scientists demonstrated that targeted small-molecule degradation of an expanded G4C2 RNA repeat [r(G4C2)exp] was a strategy for mitigating amyotrophic lateral sclerosis and frontotemporal dementia (c9ALS/FTD)-associated pathologies and studying disease-associated pathways in preclinical models.
[Science Translational Medicine]
7992332
BBBBBBBB
items
1
apa
0
default
asc
1
168470
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/